Healthcare
Definitive Healthcare Corp.(DH)
Live Price
Offline$0.76
-3.80% today
1Y Change
-80.21%
Window
Jun 25, 2025 โ Jun 18, 2026
- Market Cap
- $100.00M
- Revenue Growth
- -4.2%
- EPS Growth
- +63.3%
- Dividend Yield
- 0.0%
Coverage: 247 bars ยท Jun 25, 2025 โ Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Definitive Healthcare Corp. (DH) is a Healthcare stock with a market cap of $100.00M and listed on NASDAQ. The stock last traded around $0.76 and down 80.2% across the available one-year price window (Jun 25, 2025 โ Jun 18, 2026). Baseline metrics include revenue growth of -4.2%, EPS growth of +63.3%, a dividend yield of 0.0%. What stands out right now is revenue -4.2%, EPS +63.3%, free cash flow -19.2% with operating margin -8.5% and ROIC -3.3%. Valuation is more restrained than many high-expectation growth names at price/sales 0.4. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines DH price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-4.2% vs +7.6% peer median
Operating Margin
Below sector median
-8.5% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 14, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at -4.2% and EPS is at +63.3%, with operating margin around -8.5%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -5.0% over the next 5 trading days and finished higher after 1 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 14, 2026 | โ | -6.0% | -4.7% | -2.3% |
2026 Feb 26, 2026 | +0.0% | -8.6% | -12.9% | -22.1% |
2025 Nov 6, 2025 | +16.7% | +10.6% | +2.6% | -6.4% |
Benchmark Edge
DH vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
DH
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
DH Max Drawdown
-82.33%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for DH and SPY.
Company Overview
Definitive Healthcare Corp.
NASDAQ Global Select
Definitive Healthcare Corp., together with its subsidiaries, provides healthcare commercial intelligence in the United States. Its solutions provide information on healthcare providers and their activities to help its customers in the area ranging from product development to go-to-market planning, and sales and marketing execution. The company's platform offers 16 intelligence modules that cover functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate companies, financial institutions, and other organizations in the healthcare ecosystem. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.
- Leadership
- Kevin D. Coop
- IPO Date
- Sep 15, 2021
- Employees
- 782
- Street Address
- 550 Cochituate Road
- Mailing
- Framingham, MA, 01701
- Region
- Framingham, MA, US
- Reporting Currency
- USD
- Investor Line
- 508 720 4224
- Last Updated
- Apr 28, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- โ
- Price/Sales
- 0.4
- Price/Book
- 0.4
Growth
- Revenue
- -4.2%
- EPS
- +63.3%
- Free Cash Flow
- -19.2%
Profitability
- Gross Margin
- 75.9%
- Operating Margin
- -8.5%
- Net Margin
- -57.5%
- ROE
- -46.6%
- ROIC
- -3.3%
Balance Sheet
- Debt/Equity
- 0.63
- Current Ratio
- 1.64
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.